Elsa Anes is Full Professor in Microbiology and Immunology at the Faculty of Pharmacy University of Lisbon (FFUL). She obtained the degree in Pharmaceutical Sciences in 1988 and started her teaching career as Assistante Professor at FFUL. The PhD work focused on the construction of bacteriophage Ms6 based integrative vectors for the development of recombinant vaccines in BCG, under the supervision of Prof. Moniz Pereira. After the PhD in Pharmacy-Microbiology in 1998, she moves the research area to the Cell Biology of Mycobacteria Infection. In 2000, she did a post graduation in Molecular Biology of the Cell (Alice Dautry, Daniel Louvard, Pascale Cossart) at the Institute Pasteur, Paris a starting point for a postdoctoral formation at EMBL in Heidelberg (Gareth Griffiths laboratory), with the support of EMBO and Gulbenkian fellowships (2000-2005). Her work focused on the role of cytoskeleton during mycobacteria phagocytosis to decipher pathways of tuberculosis bacilli pathogenesis. ______________________________________________________________________________________________________________________________ In parallel she started her independent research group at Retrovirus and Associated Infections unit- Molecular Center for Pathogenesis, faculty of Pharmacy-ULisboa (URIA-CPM-FFUL) as head of the Host-Mycobateria Interactions group. In 2007, she was accepted as external group leader at the Institute of Molecular Medicine, FMUL after positive evaluation by an international group of experts (Ulrich Schaible, H.C.Krausslich, Anne O'Garra, Philippe Sansonetti, Alain Fischer). Since 2014 she is the head of Host-Pathogen Interactions (HPI) laboratory, Research Institute for Medicines (iMed-FFUL). As a pharmacist trained in microbiology, immunology and cell biology, she focus the research on host cell factors that contribute to TB control as well as the M. tuberculosis factors that this pathogen uses to highjack host cells: how it manipulates gene expression, the cytoskeleton, vesicle trafficking, and innate/adaptive immune responses including inflammasome activation and the activity of antimicrobial proteases. In addition she has been enrolled in the development of new antimycobacterials targeting TB bacilli. Her lab is providing the basis for the development of novel therapeutic and diagnostic for TB including during co-infection with HIV. ___________________________________________________________________________________________________________________________ Simultaneously to the research activities as Professor at FFUL she coordinated Cellular Biology, and presently Immunology (both from MICF course near 250 students per year), Cellular Microbiology and Applied Microbiology (2nd cycle masters, near 30 students per year). She has published more than 50 articles/book chapters in international journals, gathering more than 2100 citations (H-index=25 scopus); successfully supervised several MSc, PhD and Post-doctoral fellows; has been PI in several competitive funded grants. She participated as teacher in International PhD programmes as the EMBL pre-doc course (2000-2005); The EMBO/University of Cape Town PhD and post-doc course On Functional Microscopy of Host Pathogen Interactions (Elsa Anes, Phillipe Bastien, Gareth Griffiths, Jacomine Krijnse Locker, Rainer Pepperkok, David Russel, Ulrich Schaible, Michael Way, Peer Bork, Timo Zimmermann), South Africa 2005. Elsa Anes has been invited to participate in the evaluation process of grants and projects by several national (e.g., FCT) and international (e.g., European Commission) programs like HADEA Horizon HLTH-2022 Europe, Agence Nacional de Researche (ANR) France, South Africa National Research Foundation, Medical Research Council, UK, Biotechnology and Biological Sciences Research Council UKRI (UK research and innovation) and, Welcome Trust. She is Associate editor at Frontiers in Immunology /Frontiers in Tuberculosis and review editor in several scientific journals.